FrancophonIA/ELRC3.0 huggingface dataset:
English: • stomach ulcers or bleeding in the stomach or gut;
Slovenian: • ranami v želodcu ali krvavitvami v želodcu oziroma črevesju;
English: (obstruction of the arteries in the arms or legs), or cerebrovascular disease (problems affecting the blood vessels in the brain).
Slovenian: (boleznijo srca zaradi slabe oskrbe s krvjo), boleznijo perifernih arterij (zaporo arterij v rokah in nogah) ali cerebrovaskularnim obolenjem (težavami, ki vplivajo na krvne žile v možganih).
English: Dynastat is a medicine that contains the active substance parecoxib.
Slovenian: Dynastat je zdravilo, ki vsebuje zdravilno učinkovino parekoksib.
English: • severe liver disease;
Slovenian: • vnetnimi boleznimi črevesja;
English: For elderly patients weighing less than 50 kg and for patients with moderate liver problems, treatment is with half the usual recommended dose of Dynastat, with a maximum daily dose of 40 mg. Dynastat must not be used in patients with severe liver problems.
Slovenian: Starejše bolnike, ki tehtajo manj kot 50 kg, in bolnike z zmerno okvaro jeter je treba zdraviti s polovico običajno priporočenega odmerka zdravila Dynastat, pri čemer pa je najvišji dovoljeni dnevni odmerek 40 mg.
English: • heart failure (an inability of the heart to pump enough blood around the body), ischaemic heart disease (disease of the heart caused by failure in the blood supply), peripheral artery disease
Slovenian: • srčnim popuščanjem (nezmožnostjo srca črpati dovolj krvi po telesu), ishemično srčno boleznijo
English: Why has Dynastat been approved?
Slovenian: Zakaj je bilo zdravilo Dynastat odobreno?
English: The full EPAR for Dynastat can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Dynastat je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports Za več informacij o zdravljenju z zdravilom Dynastat preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Some of the studies also looked at the impact of giving Dynastat on the patient's use of morphine for additional pain relief after surgery.
Slovenian: V nekaterih študijah so ob sočasni uporabi morfina opazovali tudi vpliv uporabe zdravila Dynastat za dodatno lajšanje bolečine po kirurškem posegu.
English: For the full list of all side effects reported with Dynastat, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Dynastat, glejte navodilo za uporabo.
English: Dynastat was effective in relieving moderate to severe pain after an operation.
Slovenian: Zdravilo Dynastat je bilo učinkovito pri ublažitvi zmernih do hudih bolečin po operaciji.
English: • inflammatory bowel disease;
Slovenian: • hudimi obolenji jeter;
English: How has Dynastat been studied?
Slovenian: Kako je bilo zdravilo Dynastat raziskano?
English: The active substance in Dynastat, parecoxib, is a ‘prodrug' of valdecoxib.
Slovenian: Zdravilna učinkovina zdravila Dynastat, parekoksib, je „predzdravilo“ valdekoksiba.
English: What is Dynastat used for?
Slovenian: Za kaj se zdravilo Dynastat uporablja?
English: How does Dynastat work?
Slovenian: Kako zdravilo Dynastat deluje?
English: Dynastat is given at a dose of 40 mg, followed by further doses of 20 or 40 mg as required every six to 12 hours, with a maximum dose of 80 mg a day.
Slovenian: Zdravilo Dynastat se daje v odmerku 40 mg, ki mu sledita nadaljnja odmerka po 20 ali 40 mg, odvisno od potrebe, vsakih 6 do 12 ur, vendar ne več kot 80 mg na dan. Injekcijo se lahko daje bodisi hitro in neposredno v veno ali obstoječi intravenski kanal (tanko cevko, nameščeno v veno) bodisi počasi in globoko v mišico.
English: What is Dynastat?
Slovenian: Kaj je zdravilo Dynastat?
English: How is Dynastat used?
Slovenian: Kako se zdravilo Dynastat uporablja?
English: Date of first authorisation: 04/11/2009 Date of latest renewal: 22 August 2014
Slovenian: Datum prve odobritve: 4. november 2009 Datum zadnjega podaljšanja: 22. avgust 2014
English: Talk to your doctor if any of the above applies to you.
Slovenian: Obvestite svojega zdravnika, če se karkoli od naštetega nanaša na vas.
English: Repaglinide Krka has no or negligible influence on the ability to drive and use machines but may cause hypoglycaemia.
Slovenian: Zdravilo Repaglinide Krka nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji, vendar pa lahko povzroči hipoglikemijo.
English: Periodic monitoring is necessary to detect inadequate lowering of blood glucose at the recommended maximum dose level (i.e. primary failure) and to detect loss of adequate blood-glucoselowering response after an initial period of effectiveness (i.e. secondary failure).
Slovenian: Redno spremljanje je potrebno zato, da bi odkrili nezadostno znižanje glukoze v krvi ob priporočenem največjem odmerka (tj. primarna odpoved), ali nezadostno znižanje glukoze po uvodnem obdobju učinkovitosti (tj. sekundarna odpoved).
English: Tell your doctor or pharmacist if you are taking or have recently taken any other medicines.
Slovenian: Druga zdravila in zdravilo Repaglinide Krka Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: The amount of Repaglinide Krka, food or exercise may need to be adjusted.
Slovenian: Morda bo treba prilagoditi odmerek zdravila Repaglinide Krka, količino zaužite hrane ali stopnjo telesne dejavnosti.
English: 30 tablets 60 tablets 90 tablets 120 tablets 270 tablets 360 tablets
Slovenian: 30 tablet 60 tablet 90 tablet 120 tablet 270 tablet 360 tablet
English: Boxes of 30, 60, 90, 120, 270 or 360 tablets in blister are available.
Slovenian: Na voljo so škatle s 30, 60, 90, 120, 270 ali 360 tabletami v pretisnih omotih.
English: Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces.
Slovenian: Sladkorna bolezen tipa 2 je bolezen, pri kateri trebušna slinavka (pankreas) ne tvori dovolj inzulina, da bi uravnal koncentracijo sladkorja v krvi ali pa se vaše telo ne odziva normalno na inzulin, ki ga sam proizvaja.
English: Rare (may affect up to 1 in 1,000 people): • Acute coronary syndrome (but it may not be due to the medicine)
Slovenian: Redki (pojavijo se lahko pri največ 1 od 1.000 bolnikov) - akutni koronarni sindrom (ki pa ni nujno povezan z uporabo zdravila)
English: Blister pack (OPA/Alu/PVC-Alu): 30, 60, 90, 120, 270 and 360 tablets in the box.
Slovenian: Pretisni omot (OPA/Al/PVC-Al): 30, 60, 90, 120, 270 in 360 tablet v škatli.
English: Patients who skip a meal (or add an extra meal) should be instructed to skip (or add) a dose for that meal.
Slovenian: Bolniku morate naročiti, naj v primeru, če izpusti (ali zaužije dodatni) obrok, izpusti (ali vzame dodatni) odmerek za tisti obrok.
English: - Rare (1/10,000 to <1/1,000) - Very rare (<1/10,000) - Not known (cannot be estimated from the available data)
Slovenian: Pogostnost je opredeljena kot: pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
English: Do not take more Repaglinide Krka than your doctor has recommended.
Slovenian: Ne vzemite večjega odmerka zdravila Repaglinide Krka, kot vam ga je predpisal zdravnik.
English: Do not take this medicine if you are under 18 years of age.
Slovenian: Bolniki, mlajši od 18 let, tega zdravila ne smejo jemati.
English: What you need to know before you take Repaglinide Krka).
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Repaglinide Krka).
English: If you miss a dose, take the next dose as usual.
Slovenian: Če ste pozabili vzeti uporabiti zdravilo Repaglinide Krka Če ste pozabili vzeti odmerek, naslednji odmerek vzemite kot ponavadi.
English: What Repaglinide Krka is and what it is used for
Slovenian: Kaj je zdravilo Repaglinide Krka in za kaj ga uporabljamo
English: Repaglinide Krka may not be suitable for you.
Slovenian: Zdravljenje z zdravilom Repaglinide Krka pri vas morda ni primerno.
English: Repaglinide is not affected by renal disorders (see section 5.2).
Slovenian: Bolezni ledvic ne vplivajo na repaglinid (glejte poglavje 5.2).
English: Repaglinide pharmacokinetics are characterised by low volume of distribution, 30 L (consistent with distribution into intracellular fluid) and is highly bound to plasma proteins in humans (greater than
Slovenian: Za farmakokinetiko repaglinida je značilen majhen volumen porazdelitve (30 l), kar je v skladu s porazdelitvijo v znotrajcelični tekočini, vezava na plazemske proteine pri človeku pa je obsežna (več kot 98 %).
English: Repaglinide Krka has been shown to lower the blood sugar, which helps to prevent complications from your diabetes.
Slovenian: Zdravilo Repaglinide Krka dokazano znižuje vrednost krvnega sladkorja, kar pomaga preprečiti razvoj zapletov zaradi sladkorne bolezni.
English: Repaglinide Krka can also be given with metformin, another medicine for diabetes.
Slovenian: Zdravilo Repaglinide Krka se lahko jemlje skupaj z metforminom, drugim zdravilom za zdravljenje sladkorne bolezni.
English: If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take Repaglinide Krka.
Slovenian: Če jemljete gemfibrozil (zdravilo za zdravljenje zvišane vrednosti maščob v krvi), zdravila Repaglinide Krka ne smete jemati.
English: You can take Repaglinide Krka with metformin, another medicine for diabetes, if your doctor prescribes it.
Slovenian: Zdravilo Repaglinide Krka lahko vzamete jemljete skupaj z metforminom, drugim zdravilom za zdravljenje sladkorne bolezni, če vam takšno zdravljenje predpiše zdravnik tako predpiše.
English: Seven days pre-treatment with rifampicin (600 mg) followed by coadministration of repaglinide (a single dose of 4 mg) at day seven resulted in a 50% lower AUC (effect of a combined induction and inhibition).
Slovenian: Pri sedemdnevnem predzdravljenju z rifampicinom (v odmerku 600 mg) in kasnejšemu dodatku repaglinida (v enkratnem odmerku 4 mg) sedmi dan, se je vrednost AUC znižala za 50 % (kombinirani učinek indukcije in inhibicije).
English: Nederland KRKA Belgium, SA.
Slovenian: KRKA Belgium, SA.
English: Each tablet contains 0.5 mg, 1 mg or 2 mg repaglinide.
Slovenian: Ena tableta vsebuje 0,5 mg, 1 mg, 2 mg repaglinida.
English: Repaglinide Krka is not recommended in patients with moderate liver disease.
Slovenian: Uporaba zdravila Repaglinide Krka pri bolnikih z zmerno boleznijo jeter ni priporočljiva.
English: KRKA PharmaGmbH, Wien Tel: + 43 (0)1 66 24 300
Slovenian: KRKA Pharma GmbH, Wien Tel: + 43 (0)1 66 24 300
English: Repaglinide Krka is used to control type 2 diabetes in adults as an add-on to diet and exercise: treatment is usually started if diet, exercise and weight reduction alone have not been able to control (or lower) your blood sugar.
Slovenian: Zdravilo Repaglinide Krka uporabljamo za obvladovanje sladkorne bolezni tipa 2 pri odraslih bolnikih kot dodatek k dieti in telesni dejavnosti: zdravljenje je treba uvesti, če samo z dieto, telesno dejavnostjo in zmanjšanjem telesne mase vrednosti sladkorja v krvi ni mogoče nadzirati (ali znižati).
English: Repaglinide Krka is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose).
Slovenian: Zdravilna učinkovina zdravila Repaglinide Krka je repaglinid, ki trebušni slinavki pomaga, da tvori več inzulina in tako znižuje vrednost krvnega sladkorja (glukoze).
English: Alcohol can change the ability of Repaglinide Krka to reduce the blood sugar.
Slovenian: Zdravila Repaglinide Krka skupaj z alkoholom Alkohol lahko spremeni sposobnost zdravila Repaglinide Krka, da zniža vrednost krvnega sladkorja.
English: How to take Repaglinide Krka
Slovenian: Kako jemati zdravilo Repaglinide Krka
English: • if you take other medicines or suffer from liver or kidney problems (see other sections of 2.
Slovenian: To se lahko zgodi: - če ste vzeli prevelik odmerek zdravila Repaglinide Krka, - če ste telesno bolj dejavni kot ponavadi, - če uporabljate druga zdravila ali imate težave z jetri ali ledvicami (glejte ostale dele poglavja 2.
English: What Repaglinide Krka looks like and contents of the pack The 0.5 mg tablets are white, round and biconvex with bevelled edges.
Slovenian: Izgled zdravila Repaglinide Krka in vsebina pakiranja 0,5-mg tablete so bele, okrogle in izbočene, s posnetim robom.
English: If you take too many tablets, your blood sugar may become too low, leading to a hypo.
Slovenian: Če ste vzeli večji odmerek zdravila Repaglinide Krka, kot bi smeli Če vzamete preveč tablet, se vam lahko krvni sladkor preveč zniža, kar lahko vodi do hipe.
English: • if you have a severe liver disease.
Slovenian: - če imate težave z jetri.
English: Repaglinide Krka should be taken with caution.
Slovenian: V tem primeru morate zdravilo Repaglinide Krka uporabljati previdno.
English: What you need to know before you take Repaglinide Krka
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Repaglinide Krka
English: Τηλ: + 30 210 625 6177
Slovenian: QUALIA PHARMA S.A. Τηλ: + 30 210 625 6177
English: Do not take a double dose to make up for a forgotten tablet.
Slovenian: Ne vzemite dvojnega odmerka.
English: Repaglinide Krka should not be taken if you have a severe liver disease (see Do not take Repaglinide Krka).
Slovenian: Bolniki s hudo boleznijo jeter pa zdravila Repaglinide Krka ne smejo jemati (glejte odstavek Ne jemljite zdravila Repaglinide Krka).
English: Repaglinide Krka 0.5 mg tablets The tablets are white, round and biconvex with bevelled edges.
Slovenian: Repaglinide Krka 0,5 mg tablete Tablete so bele, okrogle in izbočene s posnetim robom.
English: Repaglinide Krka 0.5 mg tablets Each tablet contains 0.5 mg repaglinide.
Slovenian: Repaglinide Krka 0,5 mg tablete Ena tableta vsebuje 0,5 mg repaglinida.
English: Each tablet contains 2 mg repaglinide.
Slovenian: Ena tableta vsebuje 2 mg repaglinida.
English: If concomitant use is necessary, careful monitoring of blood glucose and close clinical monitoring should be performed.
Slovenian: Če je sočasno jemanje teh dveh zdravil nujno, je treba pazljivo nadzirati vrednosti glukoze v krvi in bolnika natančno klinično spremljati.
English: Repaglinide Krka 0.5 mg tablets Repaglinide Krka 1 mg tablets Repaglinide Krka 2 mg tablets Repaglinide
Slovenian: Repaglinide Krka 0,5 mg tablete Repaglinide Krka 1 mg tablete Repaglinide Krka 2 mg tablete repaglinid
English: Repaglinide Krka 2 mg tablets 30 tablets: EU/1/09/579/013
Slovenian: Repaglinide Krka 2 mg tablete 30 tablet: EU/1/09/579/013
English: Repaglinide Krka 2 mg tablets
Slovenian: Repaglinide Krka 2 mg tablete
English: Repaglinide Krka 2 mg tablets Each tablet contains 2 mg repaglinide.
Slovenian: Repaglinide Krka 2 mg tablete Ena tableta vsebuje 2 mg repaglinida.
English: Repaglinide Krka 0.5 mg tablets Repaglinide Krka 1 mg tablets Repaglinide Krka 2 mg tablets
Slovenian: Repaglinide Krka 0,5 mg tablete Repaglinide Krka 1 mg tablete Repaglinide Krka 2 mg tablete
English: Repaglinide Krka 0.5 mg tablets
Slovenian: Repaglinide Krka 0,5 mg tablete repaglinid
English: Repaglinide Krka 1 mg tablets Each tablet contains 1 mg repaglinide.
Slovenian: Repaglinide Krka 1 mg tablete Ena tableta vsebuje 1 mg repaglinida.
English: Repaglinide Krka 0.5 mg tablets 30 tablets: EU/1/09/579/001
Slovenian: Repaglinide Krka 0,5 mg tablete 30 tablet: EU/1/09/579/001
English: Repaglinide Krka 1 mg tablets
Slovenian: Repaglinide Krka 1 mg tablete repaglinid
English: • Hypersensitivity (such as rash, itchy skin, reddening of the skin, swelling of the skin)
Slovenian: Neželeni učinki neznane pogostnosti - preobčutljivost (npr. izpuščaj, srbeča koža, pordelost kože, oteklost kože) - siljenje na bruhanje (navzeja)
English: 120 tablets: EU/1/09/579/004 270 tablets: EU/1/09/579/005 360 tablets: EU/1/09/579/006
Slovenian: 120 tablet: EU/1/09/579/004 270 tablet: EU/1/09/579/005 360 tablet: EU/1/09/579/006
English: Repaglinide Krka 1 mg tablets 30 tablets: EU/1/09/579/007
Slovenian: Repaglinide Krka 1 mg tablete 30 tablet: EU/1/09/579/007
English: 120 tablets: EU/1/09/579/016 270 tablets: EU/1/09/579/017 360 tablets: EU/1/09/579/018
Slovenian: 120 tablet: EU/1/09/579/016 270 tablet: EU/1/09/579/017 360 tablet: EU/1/09/579/018
English: 120 tablets: EU/1/09/579/010 270 tablets: EU/1/09/579/011 360 tablets: EU/1/09/579/012
Slovenian: 120 tablet: EU/1/09/579/010 270 tablet: EU/1/09/579/011 360 tablet: EU/1/09/579/012
English: How to store Repaglinide Krka
Slovenian: Shranjevanje zdravila Repaglinide Krka
English: Talk to your doctor before taking Repaglinide Krka:
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom jemanja zdravila Repaglinide Krka se posvetujte z zdravnikom:
English: It has not been studied in these age groups.
Slovenian: Uporaba zdravila Repaglinide Krka ni priporočljiva, saj njegova uporaba v teh starostnih skupinah ni bila raziskana.
English: Repaglinide Krka 1 mg tablets The tablets are pale brown-yellow, round, biconvex with bevelled edges and possible darker spots.
Slovenian: Repaglinide Krka 1 mg tablete Tablete so bledo rjavo-rumene, okrogle, izbočene s posnetim robom in z možnimi temnejšimi pikami.
English: You should not take Repaglinide Krka if you are breast-feeding.
Slovenian: Če dojite, zdravila Repaglinide Krka, ne smete jemati.
English: Tél/Tel: + 32 (0) 487 50 73 62 (BE)
Slovenian: Luxembourg/Luxemburg KRKA Belgium, SA Tél /Tel: + 32 (0) 487 50 73 62 (BE)
English: Be aware that the desired effect is not achieved if you stop taking Repaglinide Krka.
Slovenian: Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
English: Its use should be based on official recommendations.
Slovenian: Uporaba mora temeljiti na uradnih priporočilih.
English: Children who have not been previously vaccinated against seasonal influenza should receive a second dose 4 weeks after the first.
Slovenian: Otroci, ki predhodno še niso bili cepljeni proti sezonski gripi, morajo prejeti drugi odmerek štiri tedne po prvem.
English: The full EPAR for Fluenz Tetra can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Fluenz Tetra je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Fluenz Tetra.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Fluenz Tetra.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Fluenz Tetra on 4 December 2013.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Fluenz Tetra, veljavno po vsej Evropski uniji, izdala 4. decembra 2013.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Fluenz Tetra's benefits are greater than its risks and recommended that it be approved for use in the EU.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Fluenz Tetra večje od z njim povezanih tveganj, in priporočil, da se zdravilo odobri za uporabo v EU.
English: What measures are being taken to ensure the safe and effective use of Fluenz Tetra?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Fluenz Tetra?
English: It must also not be given to children with a weakened immune system due to conditions such as blood disorders, symptomatic HIV infection, cancer or certain medical treatments, nor to children who are receiving treatment with salicylates (painkillers such as aspirin).
Slovenian: Prav tako ga ne smejo prejeti otroci z oslabljenim imunskim sistemom zaradi bolezni, kot so krvne bolezni, simptomatska okužba z virusom HIV ali rak, oziroma zaradi zdravljenja z določenimi zdravili ali otroci, ki se zdravijo s salicilati (protibolečinskimi zdravili, kot je aspirin).
English: Fluenz Tetra contains strains of flu virus that have first been weakened so that they do not cause disease.
Slovenian: Cepivo Fluenz Tetra vsebuje seve virusa gripe, ki so bili najprej oslabljeni, tako da ne povzročijo bolezni.
English: Fluenz Tetra is a vaccine used to protect children from 2 to less than 18 years of age against influenza (flu).
Slovenian: Zdravilo Fluenz Tetra je cepivo, ki se uporablja za zaščito otrok od 2. do največ 18. leta starosti proti influenci (gripi).
English: The most common side effects with Fluenz Tetra (seen in more than 1 patient in 10) are reduced appetite, headache, blocked or runny nose and malaise (feeling unwell).
Slovenian: Najpogostejši neželeni učinki zdravila Fluenz Tetra (opaženi pri več kot 1 bolniku od 10) so zmanjšan tek, glavobol, zamašen nos ali izcedek iz nosu in slabo počutje.
English: The study assessed the ability of the vaccines to stimulate an immune response against influenza, by measuring the production of protective antibodies.
Slovenian: V študiji so ocenili sposobnost cepiv za sprožanje imunskega odziva proti gripi, tako da so merili tvorbo zaščitnih protiteles.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Fluenz Tetra have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in varnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Fluenz Tetra upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo.
English: When a person is given the vaccine, the immune system recognises the virus as ‘foreign' and makes defences against it.
Slovenian: Ko oseba prejme cepivo, imunski sistem prepozna virus kot „tujek“ in začne proti njemu tvoriti protitelesa.
English: The viruses used in Fluenz Tetra are grown in hens' eggs.
Slovenian: Virusi, ki se uporabljajo v cepivu Fluenz Tetra, so vzgojeni v kokošjih jajcih.
English: Other information about Fluenz Tetra
Slovenian: Druge informacije o zdravilu Fluenz Tetra
English: Fluenz Tetra is a vaccine.
Slovenian: Zdravilo Fluenz Tetra je cepivo.
English: Fluenz Tetra must not be used in children who are hypersensitive (allergic) to the active substances or any of the other ingredients, to gentamicin (a type of antibiotic), or to eggs or egg proteins.
Slovenian: Cepiva Fluenz Tetra ne smejo prejeti otroci, ki so preobčutljivi za (alergični na) zdravilne učinkovine ali katero koli drugo sestavino zdravila, na gentamicin (vrsto antibiotika) ali na jajca oziroma jajčne beljakovine.
English: The safety profile of Fluenz Tetra is similar to Fluenz and was considered acceptable.
Slovenian: Varnostni profil cepiva Fluenz Tetra je podoben varnostnemu profilu cepiva Fluenz in je bil ocenjen kot sprejemljiv.
English: For more information about treatment with Fluenz Tetra, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Fluenz Tetra preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Of these studies the main study involved over 2,000 children aged 2 to 17 years who were vaccinated with either Fluenz Tetra or one of two Fluenz vaccines containing either one of the two influenza B strains which are also contained in Fluenz Tetra.
Slovenian: V glavni študiji je sodelovalo več kot 2 000 otrok, starih od 2 do 17 let, ki so bili cepljeni s cepivom Fluenz Tetra ali z enim od dveh cepiv Fluenz, ki vsebujeta enega od dveh sevov gripe B in ju vsebuje tudi cepivo Fluenz Tetra.
English: Influenza is mainly caused by two kinds of influenza virus, known as influenza A and B. Each of these circulates as different strains or subtypes, which change over time.
Slovenian: Gripo običajno povzročata dve vrsti virusa, tj. virus gripe A in virus gripe B. Vsak od njiju kroži v obliki različnih sevov ali podtipov, ki se sčasoma spreminjajo.